In particular, it had been previously shown that high expression of genes FREM2 (FRAS1 Related Extracellular Matrix 2) and SPRY1 (Sprouty RTK Signaling Antagonist 1) is specific to glioblastomas [29,30,31]. This evidence concerns the gene SPRY1 and glioblastoma.